PURPOSE: To report successful treatment of ocular infection caused by the microsporidium Encephalitozoon cuniculi in a person with acquired immunodeficiency syndrome (AIDS) and nasal and paranasal sinus infection. METHOD: Case report. RESULTS: Microsporidial infection in a person with AIDS and with chronic sinusitis and keratoconjunctivitis was diagnosed by Weber modified trichrome stain and transmission electron microscopy. Symptoms completely resolved with itraconazole treatment (200 mg/day for 8 weeks) after albendazole therapy (400 mg/day for 6 weeks) was unsuccessful. CONCLUSION: Itraconazole can be recommended in ocular, nasal, and paranasal sinus infection caused by E. cuniculi parasites when treatment with albendazole fails.
PURPOSE: To report successful treatment of ocular infection caused by the microsporidium Encephalitozoon cuniculi in a person with acquired immunodeficiency syndrome (AIDS) and nasal and paranasal sinus infection. METHOD: Case report. RESULTS: Microsporidial infection in a person with AIDS and with chronic sinusitis and keratoconjunctivitis was diagnosed by Weber modified trichrome stain and transmission electron microscopy. Symptoms completely resolved with itraconazole treatment (200 mg/day for 8 weeks) after albendazole therapy (400 mg/day for 6 weeks) was unsuccessful. CONCLUSION:Itraconazole can be recommended in ocular, nasal, and paranasal sinus infection caused by E. cuniculi parasites when treatment with albendazole fails.
Authors: Anna Slodkowicz-Kowalska; Thaddeus K Graczyk; Leena Tamang; Szymon Jedrzejewski; Andrzej Nowosad; Piotr Zduniak; Piotr Solarczyk; Autumn S Girouard; Anna C Majewska Journal: Appl Environ Microbiol Date: 2006-07 Impact factor: 4.792
Authors: Hung-Jui Hsu; Chia-Yi Lee; Kun-Lin Yang; Hung-Chi Chen; Chi-Chin Sun; Jing-Yang Huang; Hung-Yu Lin; Shun-Fa Yang Journal: Int J Environ Res Public Health Date: 2019-04-05 Impact factor: 3.390
Authors: Majid Moshirfar; Shaan N Somani; Kathryn M Shmunes; Ladan Espandar; Nikhil S Gokhale; Yasmyne C Ronquillo; Phillip C Hoopes Journal: Ophthalmol Ther Date: 2020-03-10